Insulet Corporation (BIT:1PODD)

Market Cap	18.52B
Revenue (ttm)	2.03B
Net Income (ttm)	372.12M
Shares Out	n/a
EPS (ttm)	5.13
PE Ratio	49.77
Forward PE	66.07
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	285.30
Previous Close	285.30
Day's Range	285.30 - 285.30
52-Week Range	284.00 - 287.90
Beta	n/a
RSI	60.00
Earnings Date	Aug 7, 2025

About Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is cont...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 3,900
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1PODD

Financial Performance

In 2024, Insulet's revenue was $2.07 billion, an increase of 22.07% compared to the previous year's $1.70 billion. Earnings were $418.30 million, an increase of 102.76%.

Financial numbers in USD